Class information for:
Level 1: AMIFOSTINE//WR 2721//WR 1065

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
9883 1111 30.6 64%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
174 3       RADIAT ONCOL//MEDICAL PHYSICS//HEAD AND NECK CANCER 58342
1172 2             AMIFOSTINE//RADIATION PNEUMONITIS//RADIATION RESEARCH 9346
9883 1                   AMIFOSTINE//WR 2721//WR 1065 1111

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMIFOSTINE authKW 4844730 27% 60% 296
2 WR 2721 authKW 965083 5% 68% 52
3 WR 1065 authKW 907410 4% 77% 43
4 RADIOPROTECTION authKW 155714 6% 9% 63
5 ETHIOFOS authKW 137415 0% 100% 5
6 EXPT HAEMATOL TOXICOL address 137415 0% 100% 5
7 ETHYOL authKW 134662 1% 70% 7
8 RADIOPROTECTOR authKW 107669 2% 15% 27
9 INDRALIN authKW 98151 0% 71% 5
10 HIGH DOSE RADIOIODINE THERAPY authKW 87944 0% 80% 4

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 9317 47% 0% 527
2 Radiology, Nuclear Medicine & Medical Imaging 6793 31% 0% 341
3 Biology 2486 14% 0% 154
4 Biophysics 521 9% 0% 98
5 Pharmacology & Pharmacy 367 13% 0% 144
6 Hematology 286 6% 0% 63
7 Nuclear Science & Technology 125 4% 0% 43
8 Toxicology 98 4% 0% 40
9 Medicine, Research & Experimental 24 3% 0% 33
10 Chemistry, Medicinal 23 2% 0% 24

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EXPT HAEMATOL TOXICOL 137415 0% 100% 5
2 EXPT HEMATOL TOXICOL 73285 0% 67% 4
3 AMRV 27483 0% 100% 1
4 BOWMAN GRAY MED GYNECOL ONCOL SECT 27483 0% 100% 1
5 BURNAZIAN FED MED BIOPHYS 27483 0% 100% 1
6 CAS BIOMED EFFECTS NANOMATERIALS NANOSA 27483 0% 100% 1
7 CDRF 27483 0% 100% 1
8 CELL PHARMACOTOXICL UNIT 27483 0% 100% 1
9 DEP HEMATOL 27483 0% 100% 1
10 EAR NOSE THROAT DIS PLAST SURG CLIN 27483 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RADIATION RESEARCH 32369 8% 1% 88
2 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 24457 11% 1% 124
3 SEMINARS IN ONCOLOGY 18963 5% 1% 60
4 INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 9096 4% 1% 41
5 SEMINARS IN RADIATION ONCOLOGY 7768 1% 2% 15
6 CANCER CLINICAL TRIALS 5358 0% 4% 5
7 STRAHLENTHERAPIE UND ONKOLOGIE 4893 2% 1% 21
8 PHARMACOLOGY & THERAPEUTICS 2610 2% 1% 17
9 PHYSIOLOGICAL CHEMISTRY AND PHYSICS 1493 0% 2% 3
10 EUROPEAN JOURNAL OF CANCER 1071 2% 0% 20

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 AMIFOSTINE 4844730 27% 60% 296 Search AMIFOSTINE Search AMIFOSTINE
2 WR 2721 965083 5% 68% 52 Search WR+2721 Search WR+2721
3 WR 1065 907410 4% 77% 43 Search WR+1065 Search WR+1065
4 RADIOPROTECTION 155714 6% 9% 63 Search RADIOPROTECTION Search RADIOPROTECTION
5 ETHIOFOS 137415 0% 100% 5 Search ETHIOFOS Search ETHIOFOS
6 ETHYOL 134662 1% 70% 7 Search ETHYOL Search ETHYOL
7 RADIOPROTECTOR 107669 2% 15% 27 Search RADIOPROTECTOR Search RADIOPROTECTOR
8 INDRALIN 98151 0% 71% 5 Search INDRALIN Search INDRALIN
9 HIGH DOSE RADIOIODINE THERAPY 87944 0% 80% 4 Search HIGH+DOSE+RADIOIODINE+THERAPY Search HIGH+DOSE+RADIOIODINE+THERAPY
10 AMIFOSTINE DOSE 82449 0% 100% 3 Search AMIFOSTINE+DOSE Search AMIFOSTINE+DOSE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 CULY, CR , SPENCER, CM , (2001) AMIFOSTINE - AN UPDATE ON ITS CLINICAL STATUS AS A CYTOPROTECTANT IN PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY OR RADIOTHERAPY AND ITS POTENTIAL THERAPEUTIC APPLICATION IN MYELODYSPLASTIC SYNDROME.DRUGS. VOL. 61. ISSUE 5. P. 641 -684 114 85% 70
2 KOUKOURAKIS, MI , (2002) AMIFOSTINE IN CLINICAL ONCOLOGY: CURRENT USE AND FUTURE APPLICATIONS.ANTI-CANCER DRUGS. VOL. 13. ISSUE 3. P. 181 -209 114 70% 68
3 SPENCER, CM , GOA, KL , (1995) AMIFOSTINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL AS A RADIOPROTECTOR AND CYTOTOXIC CHEMOPROTECTOR.DRUGS. VOL. 50. ISSUE 6. P. 1001-1031 108 86% 119
4 ORDITURA, M , DE VITA, F , ROSCIGNO, A , INFUSINO, S , AURIEMMA, A , IODICE, P , CIARAMELLA, F , ABBATE, G , CATALANO, G , (1999) AMIFOSTINE: A SELECTIVE CYTOPROTECTIVE AGENT OF NORMAL TISSUES FROM CHEMO-RADIOTHERAPY INDUCED TOXICITY (REVIEW).ONCOLOGY REPORTS. VOL. 6. ISSUE 6. P. 1357 -1362 64 94% 25
5 KOUKOURAKIS, MI , (2003) AMIFOSTINE: IS THERE EVIDENCE OF TUMOR PROTECTION?.SEMINARS IN ONCOLOGY. VOL. 30. ISSUE 6. P. 18-30 62 85% 23
6 KOUVARIS, JR , KOULOULIAS, VE , VLAHOS, LJ , (2007) AMIFOSTINE: THE FIRST SELECTIVE-TARGET AND BROAD-SPECTRUM RADIOPROTECTOR.ONCOLOGIST. VOL. 12. ISSUE 6. P. 738-747 45 82% 126
7 SANTINI, V , GILES, FJ , (1999) THE POTENTIAL OF AMIFOSTINE: FROM CYTOPROTECTANT TO THERAPEUTIC AGENT.HAEMATOLOGICA. VOL. 84. ISSUE 11. P. 1035 -1042 59 86% 60
8 ANDREASSEN, CN , GRAN, C , LINDEGAARD, JC , (2003) CHEMICAL RADIOPROTECTION: A CRITICAL REVIEW OF AMIFOSTINE AS A CYTOPROTECTOR IN RADIOTHERAPY.SEMINARS IN RADIATION ONCOLOGY. VOL. 13. ISSUE 1. P. 62-72 56 75% 102
9 CAPIZZI, RL , (1999) THE PRECLINICAL BASIS FOR BROAD-SPECTRUM SELECTIVE CYTOPROTECTION OF NORMAL TISSUES FROM CYTOTOXIC THERAPIES BY AMIFOSTINE.SEMINARS IN ONCOLOGY. VOL. 26. ISSUE 2. P. 3-21 55 83% 104
10 STANKIEWICZ, A , SKRZYDLEWSKA, E , (2006) AMIFOSTINE - ANTIOXIDANT DRUG IN ANTICANCER THERAPY.TOXICOLOGY MECHANISMS AND METHODS. VOL. 16. ISSUE 4. P. 181-188 47 84% 1

Classes with closest relation at Level 1


Rank Class id link
1 22633 RADIOPROTECTION//PODOPHYLLUM HEXANDRUM//ENDOGENOUS SPLEEN COLONY
2 31852 GS NITROXIDE//MNSOD PL//MNSOD PL GENE THERAPY
3 14435 BUTHIONINE SULFOXIMINE//L 2 OXOTHIAZOLIDINE 4 CARBOXYLATE//5 OXO L PROLINASE
4 11779 ARMED FORCES RADIOBIOL//RADIAT COUNTERMEASU PROGRAM//ACUTE RADIATION SYNDROME
5 7522 XEROSTOMIA//IMRT//INTENSITY MODULATED RADIOTHERAPY
6 30839 2 AMINO ETHYLISOTHIOURONIUM BRHBR//ADAMANTYL CELL VIABILITY//ANALOGUE HOECHST 33342
7 34975 ACCEPTOR BRIDGE DONOR//DIMER MODEL MOLECULE//EXOGENOUS ATP
8 29804 SURVIVAL EFFECT//BRADYKININ POTENTIATING FACTOR//DEPRESSION LIKE MODEL MICE
9 4853 MUCOSITIS//ORAL MUCOSITIS//PALIFERMIN
10 9048 RADIATION PROCTITIS//RADIATION ENTERITIS//PROCTITIS

Go to start page